200 related articles for article (PubMed ID: 26080893)
1. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori.
Yuan Y; Wu Q; Cheng G; Liu X; Liu S; Luo J; Zhang A; Bian L; Chen J; Lv J; Dong X; Yang G; Zhu Y; Ma L
Int J Mol Med; 2015 Aug; 36(2):363-8. PubMed ID: 26080893
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice.
Huynh HQ; Campbell MA; Couper RT; Tran CD; Lawrence A; Butler RN
Lett Appl Microbiol; 2009 May; 48(5):517-22. PubMed ID: 19187488
[TBL] [Abstract][Full Text] [Related]
3. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
[TBL] [Abstract][Full Text] [Related]
4. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Manes G; Efrati C; Hassan C; Maconi G; Piglionica D; Cannaviello C; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2007 Sep; 39(9):806-10. PubMed ID: 17644057
[TBL] [Abstract][Full Text] [Related]
7. Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study.
Ciccaglione AF; Di Giulio M; Di Lodovico S; Di Campli E; Cellini L; Marzio L
J Antimicrob Chemother; 2019 Apr; 74(4):1069-1077. PubMed ID: 30668729
[TBL] [Abstract][Full Text] [Related]
8. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy.
Manfredi M; Bizzarri B; Sacchero RI; Maccari S; Calabrese L; Fabbian F; De'Angelis GL
Helicobacter; 2012 Aug; 17(4):254-63. PubMed ID: 22759324
[TBL] [Abstract][Full Text] [Related]
10. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
12. Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo.
Tian A; Xu T; Liu K; Zou Q; Yan X
Chin Med J (Engl); 2014; 127(13):2484-91. PubMed ID: 24985588
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial.
Hablass FH; Lashen SA; Alsayed EA
Turk J Gastroenterol; 2021 Sep; 32(9):742-749. PubMed ID: 34609303
[TBL] [Abstract][Full Text] [Related]
14. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study.
Di Mario F; Aragona G; Dal Bó N; Cavallaro L; Marcon V; Olivieri P; Benedetti E; Orzès N; Marin R; Tafner G; Chilovi F; De Bastiani R; Fedrizzi F; Franceschi M; Salvat MH; Monica F; Piazzi L; Valiante F; Vecchiati U; Cavestro GM; Comparato G; Iori V; Maino M; Leandro G; Pilotto A; Rugge M; Franzè A;
Aliment Pharmacol Ther; 2006 Apr; 23(8):1235-40. PubMed ID: 16611285
[TBL] [Abstract][Full Text] [Related]
15. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy].
Parzecka M; Szaflarska-Popławska A; Mierzwa G; Gorzkiewicz M; Łuczak S; Grzybowski T
Pol Merkur Lekarski; 2009 Feb; 26(152):105-9. PubMed ID: 19388513
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori.
Wada T; Aiba Y; Shimizu K; Takagi A; Miwa T; Koga Y
Scand J Gastroenterol; 1999 Mar; 34(3):238-43. PubMed ID: 10232866
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic properties of bovine lactoferrin on Helicobacter pylori.
Dial EJ; Hall LR; Serna H; Romero JJ; Fox JG; Lichtenberger LM
Dig Dis Sci; 1998 Dec; 43(12):2750-6. PubMed ID: 9881510
[TBL] [Abstract][Full Text] [Related]
18. The Innate Immune Glycoprotein Lactoferrin Represses the Helicobacter pylori cag Type IV Secretion System.
Lu J; Haley KP; Francis JD; Guevara MA; Doster RS; Craft KM; Moore RE; Chambers SA; Delgado AG; Piazuelo MB; Damo SM; Townsend SD; Gaddy JA
Chembiochem; 2021 Sep; 22(18):2783-2790. PubMed ID: 34169626
[TBL] [Abstract][Full Text] [Related]
19. Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.
Hwang JJ; Lee DH; Kang KK; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(13):3936-43. PubMed ID: 25852279
[TBL] [Abstract][Full Text] [Related]
20. Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study.
Okuda M; Nakazawa T; Yamauchi K; Miyashiro E; Koizumi R; Booka M; Teraguchi S; Tamura Y; Yoshikawa N; Adachi Y; Imoto I
J Infect Chemother; 2005 Dec; 11(6):265-9. PubMed ID: 16369731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
